SYBX vs REGN: Which Stock is Better?

Side-by-side comparison of Synlogic Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

SYBX

Synlogic Inc

$0.64

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricSYBXREGNWinner
Market Cap$7.46M$78.87BREGN
P/E RatioN/A17.98REGN
EPS (TTM)$N/A$41.48REGN
Revenue Growth-1.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze SYBX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SYBX or REGN a better investment?

Comparing SYBX and REGN: Synlogic Inc has a market cap of $7.46M while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SYBX and REGN?

SYBX (Synlogic Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SYBX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: SYBX or REGN?

REGN has higher revenue growth at 0.0% vs -1.0% for SYBX.

Which company is more profitable: SYBX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for SYBX.

Which is the larger company: SYBX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $7.46M for SYBX.

Should I buy SYBX or REGN in 2026?

Both SYBX and REGN have investment merit. SYBX trades at $0.64 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SYBX and REGN stock?

Key differences: Market Cap ($7.46M vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons